Literature DB >> 21221725

Identification of Juxtanodin promoter and its transcriptional regulation during the ATRA-induced differentiation of C6 cells.

Tao Wang1, Lintao Jia, Guodong Yang, Shaoping Ji, Libo Yao, Bin Zhang.   

Abstract

Juxtanodin (JN) is a cytoskeleton-related oligodendrocyte-specific gene, and its underlying mechanism still needs detailed exploration. In this study, we tested whether a 1.9 kb fragment from the 5'-flanking region of JN is sufficient to specifically deliver the gene expression in oligodendrocytes. By reporter assay, we found that the 1.9 kb fragment specifically activated in C6 cells, which is further upregulated by ATRA-induced oligodendrocyte lineage differentiation. Bioinformatics study revealed that Nkx2.2 might be a transcription factor involved in the process. qPCR results showed that ATRA upregulated endogenous expression of Nkx2.2 in C6 cells. Further study revealed that Nkx2.2 could bind JN promoter and its overexpression increase the promoter activity of JN. In summary, our study here suggests that Nkx2.2 is one of the essential transcription factors delivering the specificity of JN promoter in oligodendrocytes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21221725     DOI: 10.1007/s11010-010-0696-y

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  20 in total

Review 1.  Structural properties of proteins specific to the myelin sheath.

Authors:  P Kursula
Journal:  Amino Acids       Date:  2006-12-22       Impact factor: 3.520

2.  Juxtanodin: an oligodendroglial protein that promotes cellular arborization and 2',3'-cyclic nucleotide-3'-phosphodiesterase trafficking.

Authors:  Bin Zhang; Qiong Cao; Anchen Guo; Haiying Chu; Yee Gek Chan; Jan Paul Buschdorf; Boon Chuan Low; Eng Ang Ling; Fengyi Liang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-28       Impact factor: 11.205

Review 3.  p38 Mitogen-activated protein kinase regulates myelination.

Authors:  Jeffery D Haines; Gabriela Fragoso; Shireen Hossain; Walter E Mushynski; Guillermina Almazan
Journal:  J Mol Neurosci       Date:  2007-11-10       Impact factor: 3.444

4.  Retinoic acid posttranscriptionally up-regulates proteolipid protein gene expression in C6 glioma cells.

Authors:  M López-Barahona; M Miñano; E Mira; T Iglesias; H G Stunnenberg; A Rodríguez-Peña; J Bernal; A Muñoz
Journal:  J Biol Chem       Date:  1993-12-05       Impact factor: 5.157

5.  Retinoic acid-regulated expression of proteolipid protein and myelin-associated glycoprotein genes in C6 glioma cells.

Authors:  W Zhu; M Kanoh; P Ye; I Laszkiewicz; J E Royland; R C Wiggins; G Konat
Journal:  J Neurosci Res       Date:  1992-04       Impact factor: 4.164

6.  Effects of retinoic acid on expression of the transformed phenotype in C6 glioma cells.

Authors:  I Fischer; C E Nolan; T B Shea
Journal:  Life Sci       Date:  1987-07-27       Impact factor: 5.037

7.  Most C6 cells are cancer stem cells: evidence from clonal and population analyses.

Authors:  Xuesheng Zheng; Gang Shen; Xiaofeng Yang; Weiguo Liu
Journal:  Cancer Res       Date:  2007-04-15       Impact factor: 12.701

8.  Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS.

Authors:  Stephen P J Fancy; Chao Zhao; Robin J M Franklin
Journal:  Mol Cell Neurosci       Date:  2004-11       Impact factor: 4.314

9.  Control of oligodendrocyte differentiation by the Nkx2.2 homeodomain transcription factor.

Authors:  Y Qi; J Cai; Y Wu; R Wu; J Lee; H Fu; M Rao; L Sussel; J Rubenstein; M Qiu
Journal:  Development       Date:  2001-07       Impact factor: 6.868

10.  Dual origin of spinal oligodendrocyte progenitors and evidence for the cooperative role of Olig2 and Nkx2.2 in the control of oligodendrocyte differentiation.

Authors:  Hui Fu; Yingchuan Qi; Min Tan; Jun Cai; Hirohide Takebayashi; Masato Nakafuku; William Richardson; Mengsheng Qiu
Journal:  Development       Date:  2002-02       Impact factor: 6.868

View more
  1 in total

1.  A higher proportion of ermin-immunopositive oligodendrocytes in areas of remyelination.

Authors:  Intakhar Ahmad; Stig Wergeland; Eystein Oveland; Lars Bø
Journal:  PLoS One       Date:  2021-08-26       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.